Benign prostatic hyperplasia (BPH) is the most common form of lower urinary tract symptoms (LUTS) in old men. Its incidence gradually increases with age. In recent years, the treatment mainly includes drug treatment and surgical treatment. However, the above-mentioned traditional treatment methods are difficult to achieve the purpose of relieving lower urinary tract symptoms and improving quality of life when dealing with old patients with poor health. With the development of medical level, minimally invasive treatment, as a new treatment, has potential advantages,such as small trauma, rapid recovery, less perioperative and postoperative complications, and higher quality of postoperative life. In this paper, we reviewed the minimally invasive treatment of BPH such as prostatic artery embolization (PAE), prostatic urethral lift (PUL), and transurethral columnar balloon dilation of the prostate (TUCBDP), prostate stent, in order to provide a decision-making plan for clinicians to effectively solve the problem of benign prostatic hyperplasia in old patients at high risk.